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A retrospective study of 109 skin biopsies with gra-
nuloma annulare (GA) or morphea histology from pa-
tients with suspected tick bite was performed. Biop-
sies were tested for cutaneous Borrelia burgdorferi 
DNA using PCR. The same biopsies were analysed for 
tick-borne novel agents, Chlamydia-related bacteria 
(members of the Chlamydiales order), using a PCR-
based method. Borrelia DNA was detected in 7/73 
(9.6%) biopsies with GA and in 1/36 (2.8 %) biopsies 
with morphea, while Chlamydiales DNA was found in 
53/73 (72.6%) biopsies with GA and 25/34 (73.4%) 
biopsies with morphea. All Borrelia DNA-positive GA 
samples were also positive for Chlamydiales DNA. The 
Chlamydiales sequences detected in GA were hetero-
geneous and contained Waddliaceae and Rhabdochla-
mydiaceae bacteria, which are also present in Ixodes 
ricinus ticks, while the Chlamydiales sequences detec-
ted in morphea closely resembled those found in heal-
thy skin. In conclusion, tick-mediated infections can 
trigger GA in some cases, while correlation of either 
Borrelia or Chlamydiales with morphea is unlikely. 
Key words: granuloma annulare; morphea; Borrelia burgdor-
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Granuloma annulare (GA) and morphea (localized scleroderma) are skin reactions with unknown 
aetiology (1–5). One of the possible causative agents is 
Borrelia burgdorferi sensu lato, a spirochete transmitted 
to humans via tick bites. Although the causal connections 
between B. burgdorferi and GA and morphea have been 
explored in several studies using various methods, inclu-
ding indirect serological methods and direct detection by 
PCR, there is no firm evidence of a causative role (6–11). 
In addition to B. burgdorferi sensu lato, ticks are 
known to serve as vectors for a number of other animal 
and human pathogens, such as Babesia microti, which 
causes babesiosis, Anaplasma phagocytophilum, which 
causes human granulocytic anaplasmosis, species of the 
spotted fever group of Rickettsiae, and Flavivirus, which 
causes tick-borne encephalitis (TBE) (12–15). 
Recently, Ixodes ricinus ticks have also been shown 
to carry another group of potential human pathogens, 
Chlamydia-related bacteria (16–19). They share the 
characteristic features of the order Chlamydiales: strict 
intracellular lifestyle, biphasic developmental cycle 
and a large core-set of genes. The traditional members 
of the order are the established human pathogens Chla-
mydia trachomatis and Chlamydia pneumoniae (genus 
Chlamydia, family Chlamydiaceae). During the last 20 
years, an increasing number of novel chlamydial species 
have been described and, currently, 8 additional families 
are recognized as belonging to the Chlamydiales order. 
These new families: Parachlamydiaceae, Waddliaceae, 
Simkaniaceae, Rhabdochlamydiaceae, Criblamydia-
ceae, Piscichlamydiaceae, Clavichlamydiaceae and 
Parilichlamydiaceae are collectively called Chlamydia-
related bacteria. They were originally detected in various 
types of environmental samples (e.g. soil and water 
from various sources), but subsequently also in animals, 
including arthropods, and humans. Many of them have 
pathogenic potential (20, 21), and their reservoirs, vectors 
and transmission routes have been widely investigated, 
but have mainly remained obscure.
In this study, 109 patient skin biopsies with histologi-
cally confirmed GA and localized scleroderma (morphea) 
were analysed retrospectively. The samples had been stu-
died for the presence of B. burgdorferi, either because of 
a clinical suspicion of borreliosis or because of abundant 
plasma cells in the biopsy. In order to determine whether 
certain types of Chlamydia-related bacteria could play a 
role in the pathogenesis of these conditions, the occur-
rence and type(s) of Chlamydiales in the biopsies was 
examined, and the results compared with our previously 
published data on healthy skin and ticks (17). We recently 
reported the occurrence of Chlamydiales in up to 40% of 
Finnish ticks and, furthermore, in human skin biopsies. 
Chlamydiales DNA was found in human skin samples, 
with a prevalence of 49% in healthy skin (19/39, 49%) 
and 85% in skin samples from subjects positive for B. 
burgdorferii PCR. This suggests that ticks could indeed 




Data for all patients whose skin biopsies had a histology of GA 
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at the Department of Dermatology, Helsinki University Central 
Hospital from 2010 to 2015 were reviewed. The samples were 
studied for the presence of B. burgdorferi due to clinical suspicion 
of borreliosis, history of tick bites, or the dermatopathologist’s 
recommendation based on histological features. The study in-
cluded 109 skin biopsies from 73 patients with GA and 36 with 
morphea. Clinical and serological data were retrieved from patient 
files retrospectively.
Histopathology
Histopathological analysis was performed as routine investiga-
tion in the Laboratory of Dermatopathology, Skin and Allergy 
Hospital, Helsinki University Central Hospital by an experienced 
dermatopathologist. Histological slides were available for re-
examination by one of the authors (LT) in 71 cases of GA and 34 
cases of morphea.
GA has 2 predominant histological variants, palisading and 
interstitial, both of which are characterized by mucin and dermal 
inflammation (2). The histopathology of morphea is indistin-
guishable from the skin lesion of systemic sclerosis (3). The 
histopathological findings in the samples of our patients with 
GA and morphea were classic and identical to the description in 
standard textbooks.
Detection of B. burgdorferi in skin biopsies by PCR
B. burgdorferi sensu lato DNA detection was performed as a part 
of routine diagnostics by PCR amplification and hybridization with 
16S rRNA- and OspA-specific primers and probes, as described 
earlier (6, 22). Real-time PCR with LightCycler® (Roche, Basel, 
Switzerland) was also performed. Briefly, PCR reactions contai-
ned 10 µl 2×MasterMix of the DyNAmo Flash Probe qPCR Kit 
(ThermoFisher Scientific, Waltham, MA, USA), 1 µl 10 µM the 
corresponding forward and reverse primers, 0.5 µl 10 µM probe, 
and 100 ng template DNA in a total reaction volume of 20 µl. PCR 
cycling (60 cycles of 95°C 15 s, 60°C 1 min) was performed with 
a LightCycler instrument (Roche).
Borrelia antibodies
Anti-borrelia IgG and IgM antibodies were determined by 2 
immunoassays. If the screening test (Genzyme Virotech GmbH, 
Russelsheim, Germany) was positive, a confirmatory chemilu-
minescence immunoassay (Liaison®) was performed as a routine 
procedure (Diasorin, Saluggia, Italy) by HUSLAB (23). The results 
were interpreted as described earlier (22).
Detection of Chlamydia-related bacteria in skin biopsies by PCR 
and sequencing of amplicons
Chlamydiales DNA was detected with a pan-Chlamydiales 
real-time TaqMan-PCR method, as described earlier (17, 24). 
Extreme precautions were taken to avoid cross-contamination, 
and no-template (water) controls were included in each PCR 
run. The resulting DNA amplicons (approximately 200 bp of 
the 16S rRNA gene region) were purified by Illustra ExoProStar 
Table I. Characteristics of 109 patients with granuloma annulare 
(GA) or morphea
GA Morphea
Patients, n 73 36
Male, n (%)   8 (11)   6 (17)
Female, n (%) 65 (89) 30 (83)
Age, years, mean (range) 59 (7–85) 55 (8–84)
Tick-bite recalled 17 (23)   7 (19)
Follow-up time, months, mean (range)   9 (0–55) 18 (0–55)
Localized disease, n (%) 38 (52) 20 (56)
Generalized disease, n (%) 35 (48) 16 (44)
Fig. 1. Clinical pictures of granuloma annulare (GA) and morphea skin lesions. (A) Localized GA typically presents with an annular lesion on the 
dorsum of hand. (B) Generalized GA consisting of papules coalescing into plaques in certain regions. (C) Interstitial GA may present as an erythematous 
























































357Granuloma annulare and morphea: correlation with B. burgdorferi and Chlamydia-related bacteria
Acta Derm Venereol 2018
1-Step (GE Healthcare, Buckinghamshire, UK) according to the 
manufacturer’s instructions. Sequencing was then performed at the 
sequencing unit of the Institute for Molecular Medicine Finland. 
BLAST analysis was performed in order to compare the obtained 
Chlamydiales sequences to the known sequences in the National 
Center for Biotechnology Information (NCBI) database, especially 
the Chlamydiales sequences from biopsies of healthy skin and 
from Finnish Ixodes ricinus ticks. For family-level classification, 
the first established Chlamydiales strain of the BLAST hit list 
was determined, and if the sequence identity was ≥ 90%, the 2 
sequences were considered as members of the same Chlamydiales 
family (17, 25, 26).
RESULTS
Clinical and histological findings
Clinical characteristics of the patients are summarized 
in Table I. Most patients were female. The mean age of 
patients with GA was 59 years (range 7–85 years) and 
that of the patients with morphea was 55 years (range 
8–84 years). Most of the patients did not recall having had 
a tick bite; and this has been reported even for patients 
with confirmed erythema migrans (22), since the very 
tiny nymphs fall off the skin unnoticed after feeding. 
GA was localized in 38/73 (52%) and generalized in 
35/73 (48%) of the patients (Table I, Fig. 1). Morphea 
was localized in 20/36 (56%) and generalized in 16/36 
(44%) of the patients (Table I, Fig. 1). 
Histological findings are summarized in Table II and 
visualized in Fig. 2. Of the GA cases, 38% were of the 
interstitial type. Plasma cells were present in 48% of the 
palisading GA cases and 70% of the interstitial GA cases. 
Of the morphea cases, plasma cells were present in 31/34 
(91%). No correlation between the presence of plasma 
cells and positivity for either Borrelia or Chlamydiales 
DNA could be found in either group. 










Granuloma annulare 71 31 (44) 31 (46) 7 (10)
  Palisading pattern 44 (62) 23 (52) 20 (45) 1 (2)
  Interstitial pattern 27 (38) 8 (30) 13 (48) 6 (22)
Morphea 34 3 (9) 18 (53) 13 (38)
Fig. 2. Histology of granuloma annulare (GA) and morphea. (A) and (B) Palisading GA: central area of necrobiotic collagen and mucin surrounded by 
histiocytes, lymphocytes and giant cells. (C) Interstitial GA: histiocytes and lymphocytes are scattered around collagen bundles and blood vessels. Mucin 
is prominent. In this case plasma cells are present. (D) Histology of fibrotic stage morphea is characterized by tightly packed and eosinophilic collagen 
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Prevalence of Borrelia DNA
B. burgdorferi DNA was detected in 7/73 (9.6%) of the 
GA cases and 1/36 (2.8%) of the morphea cases. Unlike 
erythema migrans, lymphocytoma or acrodermatitis 
chronica atrophicans skin samples (27), 6/7 (85.7%) of 
the above GA biopsies and the single morphea sample 
were positive only for ospA. Only one GA sample was 
positive for both ospA and 16S rRNA targets. Three of 
the 7 patients with GA had received oral antibiotics be-
fore our PCR determination (during the preceding year), 
which may have influenced the result. Most, 5/7 (71%), 
of the GA cases positive for Borrelia DNA were of the 
interstitial type.
Borrelia serology
Anti-borrelial antibodies were measured in 69 patients 
with GA and in 35 patients with morphea. The antibodies 
were defined positive in 8/69 (11%) cases of GA and in 
4/35 (11%) cases of morphea. In addition, 7/69 (10%) 
patients with GA and 4/35 (11%) patients with morphea 
had borderline antibody titres. 
The antibody levels did not correlate directly with the 
presence of Borrelia-specific DNA in the skin biopsies, 
since the only PCR-positive morphea patient and 3/7 
(43%) of the PCR-positive GA patients had only border-
line positive antibody reaction and the rest, 4/7 (57%) 
of the PCR-positive GA patients had negative serology.
Antibiotic treatments and their efficacy
All patients positive for Borrelia DNA received antibiotic 
treatment with amoxicillin, doxycycline or ceftriaxone 
with dosage recommended for Borrelia infections (27). 
Of the GA-cases positive for Borrelia DNA, 5/7 (71.4%) 
persisted regardless of adequate antibiotic therapy. One 
patient was cured with parenteral ceftriaxone treatment 
and one patient was lost to follow-up. The only morphea 
case positive for Borrelia DNA was cured with a course 
of amoxicillin and topical corticosteroid. In Borrelia 
PCR-negative cases, 40/67 (59.7%) of the GA lesions 
and 22/35 (62.9%) of the morphea lesions persisted until 
the end of the follow-up. The mean follow-up time was 
9 months for GA and 18 months for morphea patients.
Prevalence and sequence analysis of Chlamydia-related 
bacteria detected in granuloma annulare and morphea 
skin biopsies
Chlamydiales DNA was detected by PCR in 53/73 
(72.6%) of biopsies from lesions of GA, and in 25/34 
(73.4%) of biopsies from morphea. Altogether 70 sequen-
ces were obtained (45 from GA and 25 from morphea). 
When possible, the sequences were classified by BLAST 
analysis to family level. In morphea lesions, most of 
the Chlamydiales sequences belonged to the families of 
Parachlamydiaceae (56%) and Criblamydiaceae (12%), 
while 23.5% remained unclassified. Within the GA group, 
a wider range of Chlamydiales sequences were detected: 
again, the most prevalent types were Parachlamydiaceae 
(24.4%) and Criblamydiaceae (15.6%), but in addition 
to those we detected members of Waddliaceae (11.1%), 
Rhabdochlamydiaceae (4.4%) and Chlamydiaceae 
(2.2%). Within the samples from GA, 42.2% of the 
Chlamydiales sequences could not be classified to the 
family level (Fig. 3). 
All 7 GA skin biopsies positive for Borrelia DNA were 
also positive for Chlamydiales DNA. However, the single 
morphea patient positive for Borrelia DNA was negative 
when tested for Chlamydiales DNA.
Comparison of the Chlamydiales profile in GA and in 
morphea to those of healthy skin and Ixodes ricinus 
ticks (17)
The diversity of Chlamydiales sequences in skin lesions 
of morphea closely resembled that found in healthy skin 
(Fig. 3). However, in the GA lesions, the diversity was 
wider and also contained members of families Waddlia-
ceae and Rhabdochlamydiaceae, also found in Ixodes 
ricinus ticks (Fig. 3).
DISCUSSION
This study is the largest of its kind on PCR and hybridi-
zation-based detection of B. burgdorferi in patients with 
GA. Also, it is the first to inspect Chlamydiales in GA 
and morphea. According to our results on the prevalence 











Fig. 3. Chlamydiales families in the sequenced pan-Chlamydiales PCR-positive skin biopsies from lesions of granuloma annulare (GA) and 
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burgdorferi can trigger GA in some cases, but the direct 
causal role seems unlikely. The prevalence of Borrelia 
DNA in our data was 9.6%, which is in accordance 
with the few previous studies (10). It is noteworthy that 
Borrelia DNA may persist in the skin for long time (28) 
and does not necessarily reflect an active Borrelia infec-
tion. However, in our retrospective study, the presence 
of Borrelia DNA was studied because of a clinical or 
histopathological suspicion of Borrelia infection. Thus, 
the prevalence in the whole spectrum of GA may be 
somewhat lower. Since all our GA patients positive for 
Borrelia DNA were treated with appropriate antibiotics 
and in at least 71.4% of the cases GA lesions persisted 
regardless of antibiotic treatment, Borrelia infection 
does not seem to be directly causative, but rather a trig-
gering factor. This idea is supported by the finding that 
the antibody levels did not directly correlate with the 
presence of Borrelia-specific DNA. This is in accordance 
with the current literature (1). It could also be argued 
that the only Borrelia DNA positive GA patient whose 
GA lesions resolved after antibiotic treatment may have 
actually been a case of GA-like acrodermatitis chronica 
athrophicans. Four similar cases have been reported 
recently by French authors (29).
The prevalence of B. burgdorferi in morphea lesions 
has been studied much more than its correlation with 
GA. Most studies report a low or missing prevalence of 
Borrelia (10). Our result with a single case (2.8%) po-
sitive for Borrelia DNA is in accordance with previous 
studies. Because of the low prevalence, a causative or 
even triggering correlation between Borrelia infection 
and morphea is unlikely.
Members of the Chlamydiales, Chlamydia-related 
bacteria are naturally resistant to beta-lactam antibiotics, 
including amoxicillin and ceftriaxone used in the treat-
ment of Borrelia infections. However, Chlamydia-related 
bacteria should be sensitive to doxycycline (30). In our 
study, 8 patients with GA positive for Chlamydiales 
DNA were treated with doxycycline, but none of them 
was cured. This speaks against a direct causative role of 
Chlamydiales in the pathogenesis of GA. Thus, only a 
triggering effect for GA is possible.
This study has some limitations. The clinical and 
serological data were retrieved retrospectively from the 
patient files, and thus the documentation or follow-up of 
patients was not standardized. The description of possible 
systemic symptoms was vague or absent in most of the 
cases, and the majority of patients with localized disease 
was not followed after initiation of treatment, mostly 
topical corticosteroid creams or ointments.
In conclusion, Chlamydiales DNA is frequently de-
tected in skin lesion in GA and morphea. In GA, the 
Chlamydiales diversity differs from that in healthy skin 
and resembles the diversity observed in Ixodes ricinus 
ticks, suggesting a tick-derived origin. In morphea, 
however, the diversity of Chlamydiales sequences was 
close to that in healthy skin. The occasional presence of 
Borrelia DNA and the tick-like Chlamydiales diversity 
in GA lesions combined with poor response to antibio-
tic treatment favours a possible triggering role of these 
tick-mediated infections in GA. Their correlation with 
morphea, however, is unlikely.
ACKNOWLEDGEMENTS
This study was supported by Biomedicum Helsinki Foundation, 
Academy of Finland (1285975) and Helsinki University Central 
Hospital Research Funds, Helsinki, Finland. The authors would 
like to thank Leila Jeskanen, MD, for histopathological analyses, 
and Alli Tallqvist, Kaija Järvinen and Anu Kaitonen for technical 
assistance. 
REFERENCES 
1. Piette EW, Rosenbach M. Granuloma annulare: pathogenesis, 
disease associations and triggers, and therapeutic options. 
J Am Acad Dermatol 2016; 75: 467–479. 
2. Piette EW, Rosenbach M. Granuloma annulare: clinical and 
histologic variants, epidemiology, and genetics. J Am Acad 
Dermatol 2016; 75: 457–465.
3. Kreuter A. Localized scleroderma. Dermatol Ther 2012; 25: 
135–147.
4. Saracino AM, Denton CP, Orteu CH. The molecular pathogene-
sis of morphoea: from genetics to future treatment targets. 
Br J Dermatol 2017; 177: 34–46.
5. Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio 
A, Mouthon L, Cutolo M, et al. European Dermatology Forum 
S1-guideline on the diagnosis and treatment of sclerosing 
diseases of the skin, Part 1: localized scleroderma, syste-
mic sclerosis and overlap syndromes. J Eur Acad Dermatol 
Venereol 2017; 31: 1401–1424.
6. Ranki A, Aavik E, Peterson P, Schauman K, Nurmilaakso P. 
Successful amplification of DNA specific for Finnish Borrelia 
burgdorferi isolates in erythema chronicum migrans but not 
in circumscribed scleroderma lesions. J Invest Dermatol 
1994; 102: 339–345.
7. Eisendle K, Grabner T, Zelger B. Morphoea: a manifestation 
of infection with Borrelia species? Br J Dermatol 2007; 157: 
1189–1198.
8. Ziemer M, Grabner T, Eisendle K, Baltaci M, Zelger B. Granu-
loma annulare – a manifestation of infection with Borrelia? 
J Cutan Pathol 2008; 35: 1050–1057.
9. Fernandez-Flores A, Ruzic-Sabljic E. Granuloma annulare 
displaying pseudorosettes in Borrelia infection. Acta Derma-
tovenerol Alp Pannonica Adriat 2008; 17: 171–176.
10. Zollinger T, Mertz KD, Schmid M, Schmitt A, Pfaltz M, Kempf 
W. Borrelia in granuloma annulare, morphea and lichen 
sclerosus: a PCR-based study and review of the literature. 
J Cutan Pathol 2010; 37: 571–577.
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